Symposium highlights latest DPA research

Symposium highlights latest DPA research

Nutegrity's symposium gathered 13 leading lipid and fatty acid researchers and 100-plus attendees to discuss the effects of DPA on lipid metabolism in health and disease.

Nutegrity™ concluded a one-day symposium on July 2, which saw 13 leading scientists in the area of lipid and fatty acid research, and more than 100 attendees come together to discuss the biological effects of DPA on lipid metabolism in health and disease.

“The significance of DPA and its role in improving various aspects of human health is just starting to be uncovered and to be able to examine and discuss research specific to DPA is a huge benefit to myself and the scientific community,” stated symposium presenter Catherine Jane Field, Ph.D., RD, professor at the University of Alberta, Edmonton, Canada. “What was revealed throughout this symposium is that DPA has demonstrated immense promise in its ability to help reduce risk of cardiovascular disease, as well as inflammation, which is the source for most chronic illnesses. Additionally, there is a large body of research underway focusing on DPA specifically that will continue to help us piece together its unique and positive role in human health.”

Thousands of scientific studies support the health benefits of fish oils. However, many studies that have been conducted using whole fish oils have attributed the health benefits to EPA and DHA only, even though whole fish oil is a mixture of more than 40 fatty acids. Historically this has occurred because EPA and DHA are present in relatively large levels in marine oils even though they still comprise only 20 to 30 percent of fish oil by volume. DPA, an elongated version of EPA, is present in fish oil but has not received nearly as much attention from the scientific community as its relatives EPA and DHA. 

This symposium, which was held in conjunction with the International Society for the Study of Fatty Acids and Lipids (ISSFAL) conference, utilized a combination of oral presentations and posters to cover topics including:

  • Dietary sources of DPA
  • Dietary intake of DPA
  • DPA levels in various human and animal tissue, milk
  • Epidemiological data including the link between DPA and health
  • DPA and inflammation
  • DPA and vascular health

“ISSFAL is the foremost international scientific society dealing exclusively with the health impact of dietary lipids and members include scientists, medical professionals administrators, communicators and others with an interest in the health effects of dietary fats, oils and lipids,” stated Alex Byelashov, Ph.D., director of new product development, Omega Protein Corp. “Holding this symposium in conjunction with ISSFAL allowed us to tap into an audience of individuals shaping the future of fatty acid education and research and bring DPA to the forefront of the discussion.”

Symposium presenters included prominent scientists from both academia and industry including:

  • Doug Bibus, Lipid Technologies 
  • Andrew Sinclair, Deakin University (chair)
  • Bruce Holub, University of Guelph 
  • Edward A. Dennis, University of California, San Diego (chair)
  • Kaisa Linderborg, University of Turku
  • Michael Ballou, Texas Tech
  • Samuel Fortin, SCF Pharma
  • Marina Lynch, Trinity College
  • Catherine Jane Field, University of Alberta, Edmonton
  • Trond Vidar Hansen, University of Oslo
  • Yoshitaka Totebayashi, Tokyo Metropolitan Institute of Medical Science
  • Ann Skulas-Ray, Penn State University
  • Duo Li, Zhejiang University 

Individuals interested in receiving an overview of information presented at the DPA symposium, including study abstracts, please email


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.